Skip to main content

Table 2 Changes in isometric measures post-supplementation (M ± SD)

From: Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance

Variable

500 mg A-GPC

250 mg A-GPC

200 mg Caffeine

Placebo

Baseline

IMTP Peak Force (N)

3000.01 ± 611.09

2815.49 ± 504.51

3297.14 ± 768.43

3149.82 ± 885.04

Post Supplementation

IMTP Peak Force (N)

2927.82 ± 495.66

2972.48 ± 483.67

3515.24 ± 931.61*

3024.22 ± 571.99

Baseline

UBIST Peak Force (N)

632.21 ± 192.33

632.18 ± 176.29

700.07 ± 221.09

576.66 ± 259.82

Post Supplementation

UBIST Peak Force (N)

651.07 ± 189.92

678.52 ± 133.34

715.82 ± 176.78

591.975 ± 268.25

  1. * indicates significantly different than placebo (p < 0.05)